FDA Approved: DULERA — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for DULERA, a fixed-dose inhaled corticosteroid/long-acting beta-agonist from Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• DULERA (MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE)

Snippet

SUPPL AP for DULERA (MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE)